1. Home
  2. GWH vs LGVN Comparison

GWH vs LGVN Comparison

Compare GWH & LGVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo ESS Tech Inc.

GWH

ESS Tech Inc.

HOLD

Current Price

$0.21

Market Cap

26.6M

Sector

Miscellaneous

ML Signal

HOLD

Logo Longeveron Inc.

LGVN

Longeveron Inc.

HOLD

Current Price

$2.81

Market Cap

21.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
GWH
LGVN
Founded
2011
2014
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Medicinal Chemicals and Botanical Products
Sector
Miscellaneous
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
26.6M
21.4M
IPO Year
2020
2021

Fundamental Metrics

Financial Performance
Metric
GWH
LGVN
Price
$0.21
$2.81
Analyst Decision
Buy
Strong Buy
Analyst Count
2
1
Target Price
$2.25
★ $3.00
AVG Volume (30 Days)
★ 722.0K
145.0K
Earning Date
05-07-2026
05-08-2026
Dividend Yield
N/A
N/A
EPS Growth
40.71
★ 50.76
EPS
N/A
★ N/A
Revenue
★ $1,583,000.00
$709,000.00
Revenue This Year
$33.99
N/A
Revenue Next Year
$1,328.57
$10.81
P/E Ratio
N/A
★ N/A
Revenue Growth
N/A
★ N/A
52 Week Low
$0.31
$0.48
52 Week High
$13.87
$7.60

Technical Indicators

Market Signals
Indicator
GWH
LGVN
Relative Strength Index (RSI) 26.60 40.53
Support Level N/A $0.61
Resistance Level $0.40 $7.45
Average True Range (ATR) 0.04 0.42
MACD 0.00 -0.58
Stochastic Oscillator 4.81 9.24

Price Performance

Historical Comparison
GWH
LGVN

About GWH ESS Tech Inc.

ESS Tech Inc is a long-duration energy storage company specializing in iron flow battery technology. It develops and manufactures long-duration energy storage systems based on iron flow battery technology. The company's batteries use earth-abundant materials, including iron, salt, and water, and are designed for high cycle life and recyclability. It operates as a single business operating segment, which includes all activities related to the design, engineering, and manufacturing of the company's long duration energy storage products. The company's revenue is derived from the sale of its energy storage products and from service contracts.

About LGVN Longeveron Inc.

Longeveron Inc is a clinical stage biotechnology company developing regenerative medicines to address unmet medical needs. Its investigational product candidate is laromestrocel. Laromestrocel is a proprietary, scalable, allogeneic cellular therapy that has multiple potential modes of action that include pro-vascular, pro-regenerative, and anti-inflammatory mechanisms that collectively appear to promote tissue repair and healing. It is in clinical development of a single investigational product candidate, laromestrocel, for four potential indications: HLHS, Alzheimer's disease (AD), Pediatric Dilated Cardiomyopathy (pediatric DCM), and Aging-related Frailty. It operates in a single operating segment focused on developing regenerative medicines to address unmet medical needs.

Share on Social Networks: